Literature DB >> 8011413

Serum cholesterol and acute myocardial infarction: a case-control study from the GISSI-2 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico Investigators.

A Nobili1, B D'Avanzo, L Santoro, G Ventura, P Todesco, C La Vecchia.   

Abstract

OBJECTIVE: To examine the role of serum cholesterol in acute myocardial infarction in a population of patients with no history of coronary heart disease and to establish the nature of this association, the degree of risk, and the possible interaction between serum cholesterol and other major risk factors for acute myocardial infarction.
DESIGN: Case-control study.
SETTING: 90 hospitals in northern, central, and southern Italy. PATIENTS: 916 consecutive cases of newly diagnosed acute myocardial infarction and 1106 hospital controls admitted to hospital with acute conditions not related to known or suspected risk factors for coronary heart disease. DATA COLLECTION: Data were collected with a structured questionnaire and blood samples were taken by venepuncture as soon as possible after admission to hospital from cases and controls. Blood cholesterol concentrations were available for 614 cases and 792 controls.
RESULTS: After adjustment by logistic regression for sex, age, education, geographical area, smoking status, body mass index, history of diabetes and hypertension, and family history of coronary heart disease the estimated relative risks of acute myocardial infarction for quintiles of serum cholesterol (from lowest to highest) were 2.3 (95% confidence interval (CI) 1.6 to 3.4), 3.1 (95% CI 2.1 to 4.6), 4.1 (95% CI 2.8 to 6.0), and 5.2 (95% CI 3.5 to 7.7). The estimated relative risk across selected covariates increased from the lowest to the highest quintile of serum cholesterol particularly for men, patients under 55 years of age, and smokers. When the possible interaction of known risk factors with serum cholesterol was examined, smoking habits, diabetes, and hypertension had approximately multiplicative effects on relative risk.
CONCLUSIONS: This study indicates that serum cholesterol was an independent risk factor for acute myocardial infarction. This association was linear, with no threshold level. Moreover, there was a multiplicative effect between cholesterol and other major risk factors on the relative risk of acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011413      PMCID: PMC483726          DOI: 10.1136/hrt.71.5.468

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  33 in total

Review 1.  The value of lowering cholesterol after myocardial infarction.

Authors:  J E Rossouw; B Lewis; B M Rifkind
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

2.  Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?

Authors:  R Benfante; D Reed
Journal:  JAMA       Date:  1990-01-19       Impact factor: 56.272

3.  Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.

Authors:  L A Carlson; L E Böttiger
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

Review 4.  Cholesterol, lipoproteins, and coronary heart disease in women.

Authors:  T L Bush; L P Fried; E Barrett-Connor
Journal:  Clin Chem       Date:  1988       Impact factor: 8.327

5.  Geographical clustering of risk factors and lifestyle for coronary heart disease in the Scottish Heart Health Study.

Authors:  I K Crombie; W C Smith; R Tavendale; H Tunstall-Pedoe
Journal:  Br Heart J       Date:  1990-09

6.  Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study.

Authors:  D Brunner; J Weisbort; N Meshulam; S Schwartz; J Gross; H Saltz-Rennert; S Altman; K Loebl
Journal:  Am J Cardiol       Date:  1987-06-01       Impact factor: 2.778

7.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

Authors:  V Manninen; M O Elo; M H Frick; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen
Journal:  JAMA       Date:  1988-08-05       Impact factor: 56.272

8.  Cholesterol and mortality. 30 years of follow-up from the Framingham study.

Authors:  K M Anderson; W P Castelli; D Levy
Journal:  JAMA       Date:  1987-04-24       Impact factor: 56.272

9.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

10.  Risk of cancer and death in relation to serum cholesterol. A longitudinal study in an eastern Finnish population with high overall cholesterol level.

Authors:  J T Salonen
Journal:  Am J Epidemiol       Date:  1982-10       Impact factor: 4.897

View more
  1 in total

1.  Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study.

Authors:  E J Sijbrands; R G Westendorp; J C Defesche; P H de Meier; A H Smelt; J J Kastelein
Journal:  BMJ       Date:  2001-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.